Last C$0.28 CAD
Change Today 0.00 / 0.00%
Volume 10.0K
RHA On Other Exchanges
Symbol
Exchange
Venture
OTC US
As of 10:41 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

annidis corp (RHA) Snapshot

Open
C$0.28
Previous Close
C$0.28
Day High
C$0.28
Day Low
C$0.28
52 Week High
06/13/14 - C$0.35
52 Week Low
09/20/13 - C$0.16
Market Cap
26.8M
Average Volume 10 Days
7.5K
EPS TTM
C$-0.06
Shares Outstanding
95.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ANNIDIS CORP (RHA)

Related News

No related news articles were found.

annidis corp (RHA) Related Businessweek News

No Related Businessweek News Found

annidis corp (RHA) Details

Annidis Corporation engages in the research, development, and commercialization of medical devices for eye-care professionals in the United States and Canada. It offers RHA, a multi-spectral digital ophthalmoscope that helps eye-care professionals in the early detection and diagnosis of various ocular pathologies, such as glaucoma, age-related macular degeneration, and diabetic retinopathy. The company was founded in 2007 and is based in Ottawa, Canada.

Founded in 2007

annidis corp (RHA) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: --
Founder, President and Director
Total Annual Compensation: C$102.0K
Chief Financial Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

annidis corp (RHA) Key Developments

Annidis Corporation Receives Approval from China Food and Drug Administration for its RHA Gold Multi-Spectral Imaging Instrument

Annidis Corporation announced that it has received notice that the China Food and Drug Administration (CFDA) has approved the company's RHA Gold Multi-Spectral Imaging instrument to be sold to eye-care professionals in the Chinese market. The company also announced that concurrent to its CFDA approval, it has received a purchase order for twenty (20) RHA instruments from its Chinese distribution partner YIMAI Technology International Company Limited (YIMAI).

Annidis Corporation Announces Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2014

Annidis Corporation announced unaudited consolidated financial results for the first quarter ended March 31, 2014. Revenue grew by 121% to $797,989 for the three months ended March 31, 2014, compared to $361,818 for the same period in 2013. Net loss was $1,242,265 or $0.01 per share for the three months ended March 31, 2014 compared to a loss of $966,373 or $0.01 per share for the corresponding period in 2013. Net cash used in operating activities was $1,202,094 for the three months ended March 31, 2014, compared to $698,096 for the corresponding period in 2013.

Annidis Corporation Announces Audited Consolidated Results for the Three and Twelve Month Periods Ended December 31, 2013; Provides Revenue Guidance for Upcoming Quarters of 2014

Annidis Corporation announced audited consolidated results for the three and twelve month periods ended December 31, 2013. For the quarter, the company reported revenue of $319,844 compared with $483,394 for the same period in 2012. Net loss was $1,105,121 or $0.01 per share compared to a loss of $1,419,396 or $0.02 per share for the same period in 2012. Net cash used in operating activities was $1,951,790 compared to $455,139 for the corresponding period in 2012. For the twelve months, the company reported revenue was $1,066,807 compared to $1,144,077 for the same period in 2012. Net loss was $4,308,582 or $0.06 per share compared to a loss of $4,544,004 or $0.07 per share for the corresponding period in 2012. Net cash used in operating activities was $3,993,044 compared to $2,281,256 for the corresponding period in 2012. The company expect significant revenue growth in upcoming quarters as the result of this investment.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RHA:CN C$0.28 CAD 0.00

RHA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RHA.
View Industry Companies
 

Industry Analysis

RHA

Industry Average

Valuation RHA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 16.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANNIDIS CORP, please visit www.annidis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.